Lv11
10 积分 2022-02-17 加入
Conditional biologics in cancer immunotherapy: mechanisms, applications and clinical progress
10分钟前
待确认
CD39 + CD49a + CD103 + cytotoxic tissue-resident natural killer cells infiltrate and control solid epithelial tumor growth in mice
4个月前
已完结
Targeting NK cell CLEC12B enhances cancer immunotherapy
6个月前
已完结
Efficacy and safety of allogeneic CD19 CAR NK-cell therapy in systemic lupus erythematosus: a case series in China
7个月前
已完结
Engineering innate immune cells for cancer immunotherapy
1年前
已完结
The landscape of CAR-engineered innate immune cells for cancer immunotherapy
1年前
已完结
皖公网安备34019202002308
